These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10638603)

  • 1. Precipitation of iron overload and hereditary hemochromatosis after successful treatment of celiac disease.
    Heneghan MA; Feeley KM; Stevens FM; Little MP; McCarthy CF
    Am J Gastroenterol; 2000 Jan; 95(1):298-300. PubMed ID: 10638603
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemochromatosis and celiac sprue. Case report.
    Morris WE
    J Fla Med Assoc; 1993 Apr; 80(4):243-5. PubMed ID: 8505614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The iron content of the duodeno-jejunal villi. Iron absorption viewed histologically].
    Cattan D; Marche C; Jori GP; Debray C
    Nouv Rev Fr Hematol; 1967; 7(2):259-70. PubMed ID: 4228249
    [No Abstract]   [Full Text] [Related]  

  • 4. Coeliac disease and hereditary haemochromatosis: association and implications.
    Singhal A; Moreea S; Reynolds PD; Bzeizi KI
    Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):235-7. PubMed ID: 15076002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic hemochromatosis.
    Tamburro CH; Koo V
    J Ky Med Assoc; 1981 Jul; 79(7):435-43. PubMed ID: 7264447
    [No Abstract]   [Full Text] [Related]  

  • 6. Adult celiac disease and hemochromatosis.
    Turcu A; Lévêque L; Bielefeld P; Besancenot JF; Hillon P
    Am J Gastroenterol; 2000 Dec; 95(12):3661-2. PubMed ID: 11151923
    [No Abstract]   [Full Text] [Related]  

  • 7. Type 3 hemochromatosis and beta-thalassemia trait.
    Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A
    Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects.
    Cruz E; Melo G; Lacerda R; Almeida S; Porto G
    Blood Cells Mol Dis; 2006; 37(1):33-9. PubMed ID: 16762569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of "minor" genetic mutations in hereditary hemochromatosis: 2 case reports].
    Maccari S; Plancher AC
    Ann Ital Med Int; 2000; 15(3):221-5. PubMed ID: 11059064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic screening for iron overload: No evidence of discrimination at 1 year.
    Hall MA; Barton JC; Adams PC; McLaren CE; Reiss JA; Castro O; Ruggiero A; Acton RT; Power TE; Bent TC
    J Fam Pract; 2007 Oct; 56(10):829-34. PubMed ID: 17908514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary spherocytosis and hemochromatosis.
    Brandenberg JB; Demarmels Biasiutti F; Lutz HU; Wuillemin WA
    Ann Hematol; 2002 Apr; 81(4):202-9. PubMed ID: 11976822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autopsy case of hemochromatosis--with special reference to the non-iron-containing pigment (hemofuscin)].
    Ihara N; Hagihara T; Kanazawa K; Nakano E; Kondo T
    Saishin Igaku; 1970 Dec; 25(12):2576-88. PubMed ID: 4924764
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary hemochromatosis, iron, hepcidin, and coronary heart disease.
    Mascitelli L; Goldstein MR
    Med Hypotheses; 2014 Mar; 82(3):402-3. PubMed ID: 24393578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
    Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
    Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease and hemochromatosis.
    Zubizarreta E; Zapata E; Castiella A
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):589. PubMed ID: 18467924
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.
    Fracanzani AL; Conte D; Fraquelli M; Taioli E; Mattioli M; Losco A; Fargion S
    Hepatology; 2001 Mar; 33(3):647-51. PubMed ID: 11230745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis.
    Bralet MP; Duclos-Vallee JC; Castaing D; Samuel D; Guettier C
    Hepatology; 2004 Sep; 40(3):762; author reply 762. PubMed ID: 15349921
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hereditary hemachromatosis: clinical case report and literature review].
    Prochazka R; Tagle M
    Rev Gastroenterol Peru; 2006; 26(3):312-7. PubMed ID: 17053826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.